22-37084757-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001374504.1(TMPRSS6):​c.1056G>A​(p.Ser352Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.337 in 1,564,542 control chromosomes in the GnomAD database, including 90,684 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9173 hom., cov: 32)
Exomes 𝑓: 0.34 ( 81511 hom. )

Consequence

TMPRSS6
NM_001374504.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.67

Publications

24 publications found
Variant links:
Genes affected
TMPRSS6 (HGNC:16517): (transmembrane serine protease 6) The protein encoded by this gene is a type II transmembrane serine proteinase that is found attached to the cell surface. The encoded protein may be involved in matrix remodeling processes in the liver. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
TMPRSS6 Gene-Disease associations (from GenCC):
  • IRIDA syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 22-37084757-C-T is Benign according to our data. Variant chr22-37084757-C-T is described in ClinVar as Benign. ClinVar VariationId is 262719.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.67 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.377 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMPRSS6NM_001374504.1 linkc.1056G>A p.Ser352Ser synonymous_variant Exon 9 of 18 ENST00000676104.1 NP_001361433.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMPRSS6ENST00000676104.1 linkc.1056G>A p.Ser352Ser synonymous_variant Exon 9 of 18 NM_001374504.1 ENSP00000501573.1

Frequencies

GnomAD3 genomes
AF:
0.343
AC:
52029
AN:
151832
Hom.:
9174
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.382
Gnomad AMI
AF:
0.313
Gnomad AMR
AF:
0.247
Gnomad ASJ
AF:
0.272
Gnomad EAS
AF:
0.327
Gnomad SAS
AF:
0.261
Gnomad FIN
AF:
0.410
Gnomad MID
AF:
0.288
Gnomad NFE
AF:
0.342
Gnomad OTH
AF:
0.306
GnomAD2 exomes
AF:
0.312
AC:
55328
AN:
177408
AF XY:
0.311
show subpopulations
Gnomad AFR exome
AF:
0.369
Gnomad AMR exome
AF:
0.220
Gnomad ASJ exome
AF:
0.267
Gnomad EAS exome
AF:
0.320
Gnomad FIN exome
AF:
0.409
Gnomad NFE exome
AF:
0.334
Gnomad OTH exome
AF:
0.303
GnomAD4 exome
AF:
0.337
AC:
475763
AN:
1412592
Hom.:
81511
Cov.:
44
AF XY:
0.335
AC XY:
233597
AN XY:
697920
show subpopulations
African (AFR)
AF:
0.384
AC:
12497
AN:
32550
American (AMR)
AF:
0.220
AC:
8191
AN:
37174
Ashkenazi Jewish (ASJ)
AF:
0.267
AC:
6740
AN:
25276
East Asian (EAS)
AF:
0.319
AC:
11925
AN:
37378
South Asian (SAS)
AF:
0.272
AC:
21841
AN:
80230
European-Finnish (FIN)
AF:
0.408
AC:
20428
AN:
50106
Middle Eastern (MID)
AF:
0.308
AC:
1569
AN:
5086
European-Non Finnish (NFE)
AF:
0.344
AC:
373366
AN:
1086204
Other (OTH)
AF:
0.328
AC:
19206
AN:
58588
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
17044
34088
51133
68177
85221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12126
24252
36378
48504
60630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.343
AC:
52046
AN:
151950
Hom.:
9173
Cov.:
32
AF XY:
0.344
AC XY:
25561
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.382
AC:
15821
AN:
41424
American (AMR)
AF:
0.246
AC:
3765
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.272
AC:
945
AN:
3472
East Asian (EAS)
AF:
0.328
AC:
1693
AN:
5162
South Asian (SAS)
AF:
0.261
AC:
1260
AN:
4826
European-Finnish (FIN)
AF:
0.410
AC:
4328
AN:
10556
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.342
AC:
23224
AN:
67912
Other (OTH)
AF:
0.302
AC:
638
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1765
3530
5295
7060
8825
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
506
1012
1518
2024
2530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.338
Hom.:
35463
Bravo
AF:
0.334
Asia WGS
AF:
0.236
AC:
818
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcytic anemia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.48
DANN
Benign
0.85
PhyloP100
-2.7
PromoterAI
-0.013
Neutral
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2111833; hg19: chr22-37480797; COSMIC: COSV60977518; COSMIC: COSV60977518; API